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Abstract
Background: Global patterns of gene expression of Escherichia coli K-12 during growth transitions have
been deeply investigated, however, comparable studies of E. coli O157:H7 have not been explored,
particularly with respect to factors regulating virulence genes and genomic islands specific to this pathogen.
To examine the impact of growth phase on the dynamics of the transcriptome, O157:H7 Sakai strain was
cultured in MOPS minimal media (0.1% glucose), RNA harvested at 10 time points from early exponential
to full stationary phase, and relative gene expression was measured by co-hybridization on high-density
DNA microarrays. Expression levels of 14 genes, including those encoding Shiga toxins and other virulence
factors associated with the locus of enterocyte effacement (LEE), were confirmed by Q-PCR.
Results: Analysis of variance (R/MAANOVA, Fs test) identified 442 (36%) of 1239 O157-specific ORFs
and 2110 (59%) of 3647 backbone ORFs that changed in expression significantly over time. QT cluster
analysis placed 2468 of the 2552 significant ORFs into 12 groups; each group representing a distinct
expression pattern. ORFs from the largest cluster (n  = 1078) decreased in expression from late
exponential to early stationary phase: most of these ORFs are involved in functions associated with steady
state growth. Also represented in this cluster are ORFs of the TAI island, encoding tellurite resistance and
urease activity, which decreased ~4-fold. Most ORFs of the LEE pathogenicity island also decreased ~2-
fold by early stationary phase. The ORFs encoding proteins secreted via the LEE encoded type III secretion
system, such as tccP and espJ, also decreased in expression from exponential to stationary phase. Three of
the clusters (n = 154) comprised genes that are transiently upregulated at the transition into stationary
phase and included genes involved in nutrient scavenging. Upregulated genes with an increase in mRNA
levels from late exponential to early stationary phase belonged to one cluster (n = 923) which includes
genes involved in stress responses (e.g. gadAB, osmBC, and dps). These transcript levels remained relatively
high for > 3 h in stationary phase. The Shiga toxin genes (stx1AB and stx2B) were significantly induced after
transition into stationary phase.
Conclusion: Expression of more than 300 O157-specific ORFs, many implicated in virulence of the O157
pathogen, was modulated in a growth dependent manner. These results provide a baseline transcriptional
profile that can be compared to patterns of gene expression of this important foodborne pathogen under
adverse environmental conditions.
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Background
Enterohemorrhagic Escherichia coli (EHEC), a food and
water- borne pathogen of zoonotic origin, are an impor-
tant cause of acute gastroenteritis in humans. O157:H7 is
the predominant serotype of EHEC causing illness in the
United States [1]. One of the hallmarks of EHEC patho-
genesis is the formation of attaching and effacing lesions
on intestinal epithelial cells [2,3], resulting in intimate
adherence of the bacterial cell to the intestinal mucosa.
The ability to form A/E lesions is encoded by the Locus of
Enterocyte Effacement (LEE), a 35 kb pathogenicity island
[4]. Another principal virulence characteristic of EHEC is
the production of Shiga toxins, two component cytotox-
ins that inhibits protein synthesis in eukaryotic cells [5].
The genes for production of Shiga toxin (stx1 and stx2) are
located in intact or partial genomes of lambda prophages
that are inserted into the chromosome [6,7]. Together, the
LEE and Shiga toxins are considered to be two of the prin-
cipal virulence determinants that mediate development of
hemorrhagic colitis and the life-threatening hemolytic
uremic syndrome [8].
Regulation of these virulence factors is influenced by glo-
bal regulators as well as regulators specific to the virulence
factor. Many of the virulence factors in EHEC are carried
on 'foreign' DNA, DNA which is not present in E. coli K-
12, and their expression is typically regulated by transcrip-
tional regulators also carried on these mobile elements.
EHEC can utilize global regulators that are common to all
E. coli as well as O157-specific regulators to control
expression of virulence factors [8,9]. For example, the
expression of LEE is dependent on growth phase and
responds to nutrient downshifts via ppGpp signaling
through DksA to Ler (LEE encoded regulator) and PchA
[10]. Also, LEE expression can be upregulated by activa-
tion of Ler in the presence of bicarbonate ions [11], and
by quorum sensing, in which autoinducer 3 activates LEE
expression through Ler [12]. Shiga toxin expression is
linked to expression of the phage lysis genes [13,14] and
can be controlled by the iron responsive regulator Fur
[15]. In addition to the known virulence determinants, E.
coli  O157:H7 Sakai and EDL-933 contain ~1.3 Mb of
sequence not found in E. coli K-12; these sequences occur
as part of the genetic material of 18 lysogenic phages and
6 phage-like elements that have integrated into the Sakai
genome [16] and as 177 O157 strain-specific islands (OI
number) in the EDL-933 strain [17]. Recently it was iden-
tified that many effector proteins that are secreted via the
LEE-encoded type three secretion system are specified by
genes distributed throughout the genome on lambdoid
phages [18].
In general, E. coli populations are ecologically and meta-
bolically versatile and can adapt to growth under a wide
range of conditions, adaptations essential to a bimodal
lifestyle either in the primary habitat within animal hosts
or in secondary habitats as free living cells in the natural
environment [19]. Slowing metabolic activity during sta-
tionary phase reflects a survival mechanism in nutrient
poor environments in which bacteria undergo a variety of
morphological and physiological changes. In stationary
phase, E. coli are more resistant to a number of stresses,
including pH stress [20,21] and osmotic stress [22], both
of which occur during transit through the colonization of
the host intestinal tract. Important to the transmission
route of E. coli O157:H7 is the ability to persist in adverse
environments until entering a new host. Hence studying
growth transitions and how they relate to the lifestyle of
E. coli O157:H7 is essential to understanding the persist-
ence and spread of this pathogen from the bovine reser-
voir to foods and to humans.
Microarrays have been utilized to observe changes
induced in the transcriptome of E. coli during growth tran-
sitions and in response to different environmental
stresses. Global transcription profiling of E. coli K-12 indi-
cates a coordinated response to growth arrest [23]. The
sigma factor RpoS plays a crucial role in transcription of
stationary phase and stress response genes [24-26]. Micro-
array studies have been conducted to understand how E.
coli K-12 responds to growth at low pH [27,28], on rich
and minimal media [29], during anaerobic growth [30-
32], and growth transitions in rich medium [33]. Tran-
scriptional responses of O157:H7 during growth on
plasma membranes [34] and upon exposure to nor-
floxacin [35], have been investigated, and microarrays
have been used to identify genes regulated by luxS in E.
coli O157:H7 [36], but a full picture of global gene expres-
sion during growth transitions, although well-studied in
E. coli K-12, has not been investigated in the food borne
pathogen E. coli O157:H7.
A key component to understanding the adaptations and
ecology of E. coli O157:H7 is to determine how the O157-
specific genomic elements respond to one of the critical
stages of growth, stationary phase. It has been docu-
mented that some virulence factors are regulated by envi-
ronmental cues that signal the presence of the host
environment, but what is less understood is how these vir-
ulence factors are expressed in a non-host environment.
Here we address the question of how O157:H7 responds
to growth transitions by determining the changes in glo-
bal gene expression patterns in O157:H7 during the tran-
sition from exponential to stationary phase in minimal
medium, with particular interest in expression patterns of
O157-specific genes. The dynamics of the transcriptome
of E. coli O157:H7 Sakai was investigated by comparative
microarray hybridizations at 10 different time points dur-
ing exponential and stationary phase and compared to
obtain a temporal pattern of gene expression. GeneBMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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expression patterns were also verified by Q-PCR of 14
ORFs including those encoding principal virulence factors
(e.g. LEE-encoded proteins and Shiga toxins).
Results
Analysis of expression ratios
The results are based on O157:H7 Sakai cultures collected
from 10 time points of growth in minimal media with 4
replicates (i.e. 4 independent cultures that were each sam-
pled 10 times) for a total of 40 samples. The resulting
array data have been deposited in the NCBI Gene Expres-
sion Omnibus, accession GSE7477. The samples collected
from the mid-exponential phase 3-hour time point (Fig.
1) were used as a common reference for hybridization and
analysis for all subsequent time points in a replicated ref-
erence design where all the samples are biologically repli-
cated, including the reference [37]. This design allowed
for indirect comparison between all time points via the 3-
hour samples [37,38]. We incorporated the dye-swaps
among the four biological replicates which can confound
dye effects and biological replicate effects. However, if
there is significant variation in the rate of dye incorpora-
tion from one labeling reaction to another, this would
result in large dye-effects compared to biological replicate
effect [39], an effect not found in our experiments. In gen-
eral, the variance estimates for the biological replicate
effects were small (median 0.0008), compared to the var-
iance estimates (<0.5%) for the array effects (median
0.16). Most ORFs (4362/5886, 90%) had similar signal
intensities for the mid- and late- exponential phase sam-
ples, indicating that there were few overall differences in
expression between these time points (Fig. 2A and 2B). In
contrast, there were many differences in expression found
between mid-exponential phase samples and samples
from the transition point (Fig. 2C) and early stationary
phase (Fig. 2D).
Summary of significant changes in gene expression over 
time
Significant changes in expression through time were
determined using ANOVA and the Fs-test [40] for the
4,886 O157:H7 Sakai ORFs targeted on the microarray.
ANOVA does not capture how time affects gene expres-
sion, but how expression changes over time. The p values
were adjusted to correct for type I error using the Ben-
jamini-Hochberg (B-H) false discovery rate approach with
the linear step-up correction implemented in R/
MAANOVA. The B-H correction for multiple testing
applies a step-wise correction to the p values, and allows
selection of a suitable p value cutoff based on practical
considerations. The 2,552 ORFs with the lowest adjusted
p values (< 0.0000001) were considered for further analy-
sis (Additional File 1). Fold change in expression between
time points was determined by calculating the difference
in log2 expression between the time points of interest
(Additional Files 1 and 2).
Trends in gene expression identified by significant 
contrasts between subsequent time points and QT 
clustering
Expression profiles of the 2,552 ORFs with significant dif-
ferences were clustered into 12 groups using Quality
Threshold (QT) clustering (Fig. 3), which groups similar
expression profiles based on jackknife correlations [41].
The majority of ORFs were classified into 12 groups; only
84 were not placed into a cluster. ORFs were also classified
based on the time intervals at which a significant change
in gene expression occurred. A subset of 524 ORFs had dif-
ferences in expression from mid- to late-exponential
phase (3 h to 4 h). The majority of ORFs, 1,668 of 4,886
(34%), had significantly changed in transcript level at the
stationary phase transition point (4.6 to 5 h). Addition-
ally, 1,045 of 4,886 (20%) ORFs significantly changed
during the transition point to early stationary phase (5 to
5.5 h).
Significant changes in exponential phase – response to 
limiting oxygen
There were 524 ORFs with significant differences in tran-
script level during exponential phase – a total of 113 genes
changed only in exponential phase, whereas the remain-
der had altered levels of expression in exponential as well
Average growth of E. coli O157:H7 Sakai in MOPS minimal  medium Figure 1
Average growth of E. coli O157:H7 Sakai in MOPS 
minimal medium. Increase in cell density is measured at 
OD600 at 10 time periods (hr) of growth into stationary 
phase. Error bars represent the standard deviation of four 
culture replicates. Samples were taken from the culture at 
the time points plotted and RNA was extracted. The 5 
growth phases, separated by dotted lines, are defined as 
exponential growth, late exponential growth, transition to 
stationary phase, early stationary phase, and stationary phase.
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as stationary phase. ORFs that decreased in expression
included those encoding enzymes of the TCA cycle, such
as sucA, and sdhABCD (Table 1, Fig. 3; QTC 10). Many of
the ORFs (94/524, 18%) that changed in transcript level
are regulated by the transcription factor FNR [31,32],
whereas a smaller set of ORFs (29/524, 5%) are known to
be regulated by ArcA [42]. Genes that increased included
those encoding anaerobic electron acceptors, fumarate
reductase, frdAB, and DMSO reductase, dmsA and dmsC, as
well as a DMSO reductase paralog, ynfE (Table 1, Fig. 3;
Average signal intensity plots for four of the time points of growth Figure 2
Average signal intensity plots for four of the time points of growth. The normalized signals of 4,886 ORFs for E. coli 
O157:H7 Sakai were averaged from four hybridizations, representing four biological replicates: A. Average signal intensity for 
exponential phase (3 h) vs late exponential phase (4 h). B. Average signal intensity for exponential phase (3 h) vs late exponen-
tial phase (4.6 h). C. Average signal intensity for exponential phase (3 h) vs transition to stationary phase (5 h). D. Average sig-
nal intensity for exponential phase (3 h) vs. stationary phase (6 h. The Lowess line is plotted for each graph in red.BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
Page 5 of 27
(page number not for citation purposes)
Quality Threshold (QT) clusters of the 2,552 ORFs with significant changes in gene expression Figure 3
Quality Threshold (QT) clusters of the 2,552 ORFs with significant changes in gene expression. The number of 
ORFs in each cluster is listed at the top of each plot. Average expression profiles were determined for the ORFs in each clus-
ter and plotted with the standard deviation for each time point.
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Table 1: Significant ORFs (p value < 1 × 107) with greater than 4-fold significant change between 3 h and 4 h.
Ecs number Genea function log2 change in expression QT clusterb
ECs0236 O157 Unknown function -2.89 10
ECs0482 cyoE protoheme IX farnesyltransferase -2.08 10
ECs0483 cyoD cytochrome o ubiquinol oxidase subunit IV -3.18 10
ECs0484 cyoC cytochrome o ubiquinol oxidase subunit III -3.32 10
ECs0485 cyoB cytochrome o ubiquinol oxidase subunit I -3.87 10
ECs0486 cyoA cytochrome o ubiquinol oxidase subunit II -3.89 10
ECs0660 dcuC transport of dicarboxylates 2.20 6
ECs0746 sdhC succinate dehydrogenase, cytochrome b556 -3.15 10
ECs0747 sdhD succinate dehydrogenase, hydrophobic subunit -2.66 10
ECs0748 sdhA succinate dehydrogenase -3.06 10
ECs0749 sdhB succinate dehydrogenase -2.79 10
ECs0750 - orf, hypothetical protein -2.24 10
ECs0751 sucA 2-oxoglutarate dehydrogenase -2.20 10
ECs0768 cydA cytochrome d terminal oxidase 2.56 4
ECs0769 cydB cytochrome d terminal oxidase 2.58 4
ECs0916 yliH putative receptor 3.84 2
ECs0979 dmsA anaerobic dimethyl sulfoxide reductase 3.71 4
ECs0981 dmsC anaerobic dimethyl sulfoxide reductase 2.08 4
ECs0986 pflB formate acetyltransferase 1 2.04 6
ECs1572 pepT putative peptidase T 2.64 2
ECs1728 narK nitrite extrusion protein 2.98 6
ECs1729 narG nitrate reductase 1, alpha subunit 2.25 4
ECs1741 adhE CoA-linked acetaldehyde dehydrogenase 2.50 6
ECs1756 yciD putative outer membrane protein 4.15 4
ECs1875 ycjL probable amidotransferase subunit -2.28 2
ECs2027 ydcI putative transcriptional regulator LYSR-type -2.41 2
ECs2078 fdnG formate dehydrogenase-N, nitrate-inducible 2.30 6
ECs2150 ydfZ orf, hypothetical protein 4.70 4
ECs2293 ynfE putative oxidoreductase, major subunit 2.83 6
ECs2457 ydjY orf, hypothetical protein 2.03 6
ECs2463 ynjE putative thiosulfate sulfur transferase 3.47 1
ECs2614 yecH orf, hypothetical protein 3.09 6
ECs3061 fruB PTS system, fructose-specific IIA/fpr component 2.02 1
ECs3084 dsbE disulfide oxidoreductase 2.04 1
ECs3088 ccmC heme exporter protein C 2.19 1
ECs3090 ccmA ATP binding protein of heme exporter A 2.64 1
ECs3091 napC cytochrome c-type protein 3.55 1
ECs3092 napB cytochrome c-type protein 3.30 1
ECs3093 napH ferredoxin-type protein: electron transfer 3.04 un
ECs3180 ackA acetate kinase 2.28 6
ECs3226 yfcZ orf, hypothetical protein 3.02 6
ECs3445 yfiD putative formate acetyltransferase 4.48 6
ECs3460 yfiA putative yhbH sigma 54 modulator 2.12 2
ECs3582 hypA pleiotrophic effects on 3 hydrogenase isozymes 2.92 6
ECs3583 hypB guanine-nucleotide binding protein 2.10 6
ECs3586 hypE plays structural role in maturation of all 3 hydrogenases 2.10 6
ECs3799 O157 orf; hypothetical protein 2.92 6
ECs3800 O157 orf; hypothetical protein 2.33 6
ECs3802 O157 putative ATP-binding protein of ABC transport system 2.40 6
ECs3833 ansB periplasmic L-asparaginase II 3.41 4
ECs3880 hybB probable cytochrome Ni/Fe component of hydrogenase-2 2.05 4
ECs4040 yhbV orf, hypothetical protein 3.11 1
ECs4216 nirB nitrite reductase (NAD(P)H) subunit 3.55 1
ECs4343 nikA periplasmic binding protein for nickel 3.46 1
ECs4344 nikB transport of nickel, membrane protein 2.10 6
ECs4347 nikE ATP-binding protein of nickel transport system 2.85 1
ECs4398 yhjA putative cytochrome C peroxidase 2.86 6
ECs4456 yiaI orf, hypothetical protein 2.40 4
ECs4750 yigI orf, hypothetical protein -2.55 10BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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QTC 6). Genes encoding the cytochrome c biogenesis sys-
tem (ccmABCDEFG) and the cytochrome c-like protein
(napB and napC) also had a significant increase from 3 h
to 4 h. The operon encoding the low affinity cytochrome
oxidase bo (cyoABCD) decreased 9 to15- fold in expression
from 3 h to 4 h (Table 1). Concomitantly, expression of
the high affinity cytochrome oxidase bd, cydAB, increased
4–5 fold. Expression of the high and low affinity cyto-
chrome oxidases is directly influenced by the level of
available oxygen in the media [43,44]. Gene set enrich-
ment analysis (GSEA) found that genes involved in anaer-
obic energy metabolism were significantly enriched in the
4 h sample compared to the 3 h sample, and that genes
involved in aerobic energy metabolism and the TCA cycle
were significantly enriched in the 3 h compared to the 4 h
culture (Additional File 3). The altered expression of the
cytochrome oxidases as well as the increase in FNR-con-
trolled, anaerobic associated genes and decrease in TCA
cycle enzymes is consistent with the hypothesis that oxy-
gen became limiting under the culture conditions that
were used. Subsequent measurement of the residual dis-
solved oxygen tension in the culture during growth indi-
cates that residual dissolved O2 levels decreased almost to
zero (95% decrease in O2) during exponential phase (Fig.
4). As cultures entered stationary phase, the O2 levels
began to increase, as the demand for O2 by the culture
decreased.
Significant change in O157-specific genes during 
exponential phase
In contrast to the backbone genes, only a small propor-
tion (6%) of the O157-specific ORFs changed signifi-
cantly in expression measured during exponential phase.
While statistically significant, most of the differences in
expression level for these 61 genes were not substantial,
ranging from 1.2- to 2- fold (Additional File 2). Many of
these ORFs are of unknown function, but of the 45 O157-
specific ORFs that increased from 3–4 h, 9 of them were
from a single Sakai phage (Sp) 15 region which encodes
the Shiga toxin 1 phage, and contains 5 ORFs from Sp 5
which encodes the Shiga toxin 2 phage. Interestingly,
ECs2381 a locus whose expression has been shown to
contribute to colonization in the bovine gastrointestinal
tract [45], was also significantly induced 1.8 fold from 3
to 4 h. There were 4 additional O157-specific ORFs that
had a greater than 4-fold change in expression from 3–4 h
(Table 1). These 4 ORFs were not associated with any of
the Sakai phages, and have unknown or putative func-
tions.
Genes with significant changes in expression at the 
stationary phase transition point
The majority of significant changes in transcript level
occurred at the stationary phase transition point. There
were 176 ORFs with a 4-fold or greater change in expres-
sion at the stationary phase transition point (Table 2). A
total of 363 ORFs that significantly increased or decreased
during the transition to stationary phase (4.6–5 h) also
Residual dissolved oxygen (O2) in MOPS minimal medium Figure 4
Residual dissolved oxygen (O2) in MOPS minimal 
medium. The mean rDOT was determined for three inde-
pendent cultures of E. coli O157:H7 Sakai in glucose limited 
MOPS minimal medium and plotted with the error bars indi-
cating the standard deviation.
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ECs4834 sodA superoxide dismutase, manganese -2.40 7
ECs4874 gldA glycerol dehydrogenase, (NAD) 2.86 6
ECs5052 nrfA periplasmic cytochrome c(552) 3.08 un
ECs5053 nrfB formate-dependent nitrite reductase 2.86 6
ECs5054 nrfC formate-dependent nitrite reductase; Fe-S centers 2.96 un
ECs5134 frdB fumarate reductase, anaerobic, iron-sulfur protein subunit 2.50 8
ECs5135 frdA fumarate reductase, anaerobic, flavoprotein subunit 2.11 8
ECs5214 nrdG anaerobic ribonucleotide reductase activating protein 2.02 6
ECs5215 nrdD anaerobic ribonucleoside-triphosphate reductase 3.54 6
ECs5298 yjiM orf, hypothetical protein 2.76 8
aGenes in bold have been identified as being under the control of the transcriptional regulator FNR [29, 30]. Underlined genes have been identified 
as being controlled by the transcriptional regulator ArcA [40].
bQT cluster un. means unassigned
Table 1: Significant ORFs (p value < 1 × 107) with greater than 4-fold significant change between 3 h and 4 h. (Continued)BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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Table 2: Significant ORFs (p value < 1 × 107) with greater than 4-fold significant changes in expression at the stationary phase transition 
point (4.6 to 5 h).
Ecs no. Gene log2 change in 
expression
QT cluster Ecs no. Gene log2 change in 
expression
QT cluster
ECs0034 dapB -2.63 1 ECs1286 O157 -2.09 1
ECs0035 carA -4.23 1 ECs1426 mdoG -2.46 5
ECs0068 araC 2.57 2 ECs1440 pyrC -2.65 1
ECs0072 tbpA -2.25 1 ECs1468 plsX -2.16 1
ECs0083 fruL -2.06 1 ECs1479 ptsG -3.09 1
ECs0124 speD -2.74 1 ECs1492 mfd -2.33 1
ECs0149 dksA 2.12 2 ECs1604 ycfC -2.19 1
ECs0150 sfsA 2.83 2 ECs1662 O157 -2.53 1
ECs0191 yaeO 2.42 2 ECs1684 dadA 2.34 2
ECs0207 dniR -2.11 1 ECs1710 ychH 4.61 2
ECs0334 O157 -2.07 1 ECs1712 prsA -2.68 1
ECs0374 O157 2.42 2 ECs1859 rnb -2.70 1
ECs0401 mhpR 4.33 3 ECs1954 O157 -2.61 1
ECs0416 O157 3.55 2 ECs1955 O157 -3.22 1
ECs0468 ribH -2.27 1 ECs2011 ynbB 2.34 2
ECs0483 cyoD 2.06 10 ECs2021 aldA 3.60 2
ECs0485 cyoB 2.01 10 ECs2027 ydcI 3.35 2
ECs0489 bolA 2.10 2 ECs2031 ydcH 2.99 2
ECs0584 purK -2.27 1 ECs2037 ydcN 2.71 2
ECs0585 purE -2.66 1 ECs2083 sfcA -2.18 1
ECs0610 cusC -2.31 1 ECs2182 O157 3.21 2
ECs0611 cusF -2.82 1 ECs2293 ynfE -2.97 6
ECs0612 cusD -2.62 1 ECs2296 ynfH -2.03 6
ECs0613 ybdE -2.70 1 ECs2362 lhr -2.16 1
ECs0670 dacA -2.32 1 ECs2367 purR -2.51 1
ECs0681 ybeL 2.78 2 ECs2431 yniA 3.52 2
ECs0773 tolR -2.29 1 ECs2433 yniC 2.44 3
ECs0782 aroG -3.09 1 ECs2445 osmE 2.33 2
ECs0800 ybhC -2.13 1 ECs2510 yeaV 2.06 3
ECs0814 O157 -2.15 1 ECs2692 yodD 2.96 2
ECs0869 ybhQ 3.14 2 ECs2714 espJ -2.01 1
ECs0890 dps 2.64 2 ECs2737 pchC 3.43 2
ECs0943 artJ -2.81 1 ECs2814 yeeD -2.09 1
ECs0966 cspD 2.75 2 ECs2816 yeeF -2.55 1
ECs0968 clpA 2.89 3 ECs2839 O157 -2.23 1
ECs0986 pflB -2.61 6 ECs2840 wbdP -2.14 1
ECs1008 ycbB 2.15 2 ECs2847 O157 -2.25 1
ECs1029 pyrD -2.88 1 ECs3038 yeiT 2.14 3
ECs1037 rmf 2.24 2 ECs3060 fruK -2.13 1
ECs1072 O157 -2.13 5 ECs3061 fruB -2.38 1
ECs1091 O157 3.24 2 ECs3136 yfaX -2.04 1
ECs1137 yccC -2.27 1 ECs3149 menC -2.06 1
ECs1138 yccY -2.78 1 ECs3180 ackA -2.33 6
ECs1139 yccZ -2.74 1 ECs3194 argT 4.08 2
ECs3196 purF -2.94 1 ECs4188 hopD 2.38 2
ECs3197 cvpA -3.35 1 ECs4192 rpsG -2.57 1
ECs3212 mepA -2.29 1 ECs4193 rpsL -2.67 1
ECs3287 ptsH -2.66 1 ECs4204 yheT -2.00 1
ECs3296 cysP -2.17 1 ECs4249 yhgF -2.53 1
ECs3361 purM -4.24 1 ECs4294 yhhA 2.48 2
ECs3387 sseA 2.18 2 ECs4343 nikA -3.22 1
ECs3403 hcaR 2.50 3 ECs4347 nikE -2.38 1
ECs3423 purL -2.45 1 ECs4366 yhiO 4.26 2
ECs3448 trxC 2.24 2 ECs4481 lldP 2.39 2
ECs3463 tyrA 3.67 3 ECs4490 gpmI -3.35 1
ECs3464 aroF 3.30 3 ECs4512 rpmB -2.38 1
ECs3471 yfjA -3.58 1 ECs4553 O157 -2.10 1
ECs3546 emrR -3.47 1 ECs4575 escC -2.00 1BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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increased or decreased in early stationary phase (5–5.5 h)
(Table 3). A reduced level of expression of ribosomal
genes and genes involved in nucleotide and amino acid
synthesis was observed from 4.6–5 h and 5–5.5 h (Tables
2 and 3, Fig. 3; QTC 1). Many of the genes that were sig-
nificantly down-regulated upon entry into stationary
phase have been also observed in E. coli K-12 [23], includ-
ing decreased expression of the molecular chaperones
encoded by groEL, htpG, and dnaK (Tables 2 and 3, Fig. 3;
QTC 1, Additional File 1).
Expression of rpoS, encoding the stationary phase sigma
factor, increased 7 fold during the transition point and the
RpoS activator, dksA, increased 4.3 fold at the same inter-
val (Table 2). Increased expression of genes known to be
regulated by RpoS, such as bolA, dps, osmE, osmC, adhP and
ugpB  occurred at the stationary phase transition point
(Tables 2 and 3, Fig. 3; QTC 2). Gene set enrichment anal-
ysis also indicated that these genes (members of the adap-
tation to atypical conditions group) were significantly
enriched in the stationary phase time points compared to
exponential phase (Additional File 4). ORFs encoding
toxin-antitoxin systems, such as dinJ-yafQ (Table 3, Fig. 3;
QTC 2) and chpB-chpS (Fig. 3; QTC 3), were upregulated
at the stationary phase transition point. The greatest
increase in transcriptional level for an upregulated gene
(45-fold) during the stationary phase transition (4.6 to 5
h interval) was acs, encoding acetyl CoA synthetase (Table
2). Acs expression is controlled in part by RpoS [46]. Also
induced at a very high level during the transition point
into stationary phase were aceB (40 fold) and aceA (32
fold), which encode components of the glyoxalate shunt.
Increased expression of acetyl CoA synthetase as well as
genes of the glyoxalate shunt is consistent with the hypo-
thesis that cells are scavenging acetate produced during
rapid growth on glucose in exponential phase.
There are a variety of O157-specific genes that were down-
regulated in the transition to stationary phase include
those encoding the O157 LPS antigen (ECs2839,
ECs2840, and ECs2847) with a greater than 4 fold
decrease in expression (Table 3, Fig. 3; QTC 1) as well as
ECs2835, ECs2836, ECs2838, ECs2841, ECs2844, and
ECs2845 (1.6 to 3 fold decrease) from that genomic
region. ECs2113, part of the F9 fimbrial operon [47],
decreased in expression from exponential to stationary
phase (Table 3). Other ORFs in this operon, ECs2107-
2112, also decreased significantly (~1.5 fold) upon entry
into stationary phase. O157-specific ORFs that increased
in stationary phase included ECs2182, ECs2737, and
ECs5067, which encode putative transcriptional regula-
tors. ECs2737 (pchC)  encodes a perC-like homolog
ECs3559 srlA_1 2.08 3 ECs4632 yidA -2.02 1
ECs3595 rpoS 2.80 2 ECs4638 rpmH -2.47 1
ECs3606 cysD -2.59 1 ECs4639 rnpA -2.92 1
ECs3640 pyrG -2.98 1 ECs4679 atpE -2.33 1
ECs3659 fucO 2.17 3 ECs4716 rho -2.56 5
ECs3675 argA -4.09 1 ECs4720 wecC -2.34 1
ECs3677 recB -2.17 1 ECs4741 xerC -2.08 1
ECs3701 yqeF 2.50 3 ECs4756 yigL -2.18 1
ECs3743 ygeW 2.08 2 ECs4759 metE -2.76 1
ECs3749 yqeC 2.45 2 ECs4791 glnL -2.80 1
ECs3799 O157 -2.69 6 ECs4870 metF -3.65 1
ECs3800 O157 -2.43 6 ECs4885 ppc -3.62 1
ECs3802 O157 -2.43 6 ECs4887 argC -3.99 1
ECs3811 yggG 2.28 2 ECs4888 argB -3.62 1
ECs3818 metK -3.03 1 ECs4893 O157 2.09 2
ECs3840 nupG 2.44 2 ECs4907 rplA -3.02 1
ECs3931 glgS 2.94 2 ECs4908 rplJ -2.64 1
ECs4052 argG -2.68 1 ECs4909 rplL -2.60 1
ECs4103 rpsI -2.28 1 ECs4929 purH -4.14 1
ECs4132 yhdG -2.54 1 ECs4931 metA -3.78 1
ECs4150 smg 2.24 2 ECs4932 aceB 5.35 2
ECs4156 mscL 2.01 2 ECs5004 O157 2.14 2
ECs4161 rpsD -2.17 1 ECs5046 yjcD -3.81 1
ECs4162 rpsK -2.36 1 ECs5051 acs 5.55 2
ECs4164 rpmJ -2.03 1 ECs5067 O157 2.21 2
ECs4165 prlA -2.53 1 ECs5153 purA -2.06 1
ECs5164 yjfN 4.54 2 ECs5240 yjgR 2.24 2
ECs5192 cysQ 2.01 2 ECs5259 O157 -2.09 1
ECs5231 argI -3.29 1 ECs5354 rob 2.15 2
ECs5235 valS -2.58 1 ECs5360 yjjY 2.03 2
Table 2: Significant ORFs (p value < 1 × 107) with greater than 4-fold significant changes in expression at the stationary phase transition 
point (4.6 to 5 h). (Continued)BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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Table 3: Significant ORFs (p value < 1 × 107) with greater than 4-fold significant changes in expression from late exponential to early 
stationary phase (4.6 to 5.5 h)
Ecs no. Genea Log2 change in 
expression
QT cluster Ecs no. Genea Log2 change in 
expression
QT cluster
ECs0009 mogA 2.27 2 ECs0526 htpG -2.70 1
ECs0015 dnaJ -2.32 1 ECs0527 adk -3.22 1
ECs0026 rpsT -4.14 1 ECs0540 O157 3.52 2
ECs0028 ribF -2.36 1 ECs0541 O157 4.11 2
ECs0029 ileS -2.81 1 ECs0552 ybbK 3.00 2
ECs0030 lspA -2.38 1 ECs0561 ybbD 2.16 2
ECs0032 lytB -2.20 1 ECs0615 ybdG -2.36 1
ECs0036 carB -3.28 1 ECs0619 ybdK 2.98 2
ECs0052 ccdA 2.41 2 ECs0645 ahpF -2.11 1
ECs0078 leuA 2.55 un ECs0646 ybdQ 3.35 3
ECs0108 guaC -2.45 1 ECs0656 citD 2.79 2
ECs0118 aceE -3.27 1 ECs0864 ybhL 2.61 2
ECs0119 aceF -2.55 1 ECs0866 ybhN 2.27 2
ECs0123 yacL 3.17 2 ECs0881 ybiI 3.35 2
ECs0128 gcd 2.69 2 ECs0896 ybiS -2.07 1
ECs0168 dapD -3.16 1 ECs0915 yliG -2.77 1
ECs0172 tsf -4.58 1 ECs0919 dacC 2.40 2
ECs0173 pyrH -3.15 1 ECs0934 potF 2.12 2
ECs0182 fabZ -2.20 1 ECs0944 artM -2.40 1
ECs0199 yaeC -3.14 1 ECs0963 ybjX -2.08 1
ECs0200 yaeE -2.63 1 ECs0974 lrp -3.19 1
ECs0201 abc -3.32 1 ECs0979 dmsA -3.37 4
ECs0216 O157 2.02 2 ECs0989 ycaP 2.56 2
ECs0248 fadE 4.57 2 ECs0990 serC -3.29 1
ECs0253 dinJ 2.46 2 ECs0991 aroA -4.24 1
ECs0269 proB -2.11 1 ECs1007 mukB -2.12 1
ECs0383 yahO 4.53 2 ECs1013 asnS -2.74 1
ECs0384 prpR 3.63 2 ECs1014 pncB -2.37 1
ECs0390 codA -2.78 1 ECs1022 ycbR -3.16 1
ECs0415 afuA 5.21 2 ECs1048 - 2.44 2
ECs0434 psiF 3.83 2 ECs1050 yccV 3.88 2
ECs0458 yajC -2.33 1 ECs1158 agp 3.47 2
ECs0459 secD -2.40 1 ECs1159 yccJ 2.12 2
ECs0490 tig -2.96 1 ECs1211 O157 -3.29 1
ECs0497 ybaW 2.93 2 ECs1266 phoH 7.69 2
ECs0502 mdlA -3.80 1 ECs1351 terZ -2.58 1
ECs0503 mdlB 2.30 2 ECs1355 terD -2.53 1
ECs0504 glnK -3.73 1 ECs1356 terE -2.90 1
ECs0507 ybaY 3.19 2 ECs1423 - 2.34 2
ECs0509 ybaA 2.56 2 ECs1438 yceP 4.78 2
ECs0518 aefA 2.12 2 ECs1466 yceD -2.86 1
ECs1467 rpmF -2.36 1 ECs2307 ydgG -2.69 1
ECs1500 potC -2.14 1 ECs2308 pntB -2.80 1
ECs1603 purB -3.58 1 ECs2314 rstA -2.63 1
ECs1605 ycfB -2.43 1 ECs2319 manA -2.47 1
ECs1663 ompT -2.72 1 ECs2346 tyrS -2.97 1
ECs1683 ycgB 5.36 2 ECs2385 ynhG 3.80 2
ECs1692 ymgE 2.35 2 ECs2387 sufS 2.88 2
ECs1705 - 2.55 2 ECs2389 sufC 3.58 2
ECs1722 chaB 2.85 2 ECs2390 sufB 2.93 2
ECs1729 narG -2.70 4 ECs2391 sufA 3.68 2
ECs1743 oppA -2.75 1 ECs2397 - 2.44 2
ECs1747 oppF -2.11 1 ECs2423 rplT -3.11 1
ECs1831 yciG 2.91 2 ECs2430 ydiZ 2.09 2
ECs1848 - 2.73 2 ECs2450 ydjS 3.94 2
ECs1849 acnA 4.07 2 ECs2451 astB 4.11 2
ECs1858 yciR 3.14 2 ECs2452 astD 5.88 2
ECs1874 ycjK 4.73 2 ECs2453 astA 4.62 2
ECs1875 ycjL 5.14 2 ECs2454 astC 6.97 2BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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ECs1914 ydaA 2.88 2 ECs2460 - -2.03 1
ECs1997 ynaF 3.42 2 ECs2463 ynjE -4.04 1
ECs2028 ydcJ 3.64 2 ECs2467 gdhA -5.15 1
ECs2036 ydcL 3.78 2 ECs2491 yeaF -2.61 1
ECs2044 ydcS 5.22 2 ECs2492 yeaG 4.08 2
ECs2045 ydcT 5.23 2 ECs2511 yeaW 2.43 2
ECs2054 ydcU 2.59 2 ECs2514 fadD 2.50 2
ECs2082 adhP 3.62 2 ECs2519 yoaC 2.05 2
ECs2084 rpsV 2.45 2 ECs2527 manX -2.95 1
ECs2086 osmC 2.01 2 ECs2528 manY -3.21 1
ECs2091 - 3.38 2 ECs2546 ydjX 4.09 2
ECs2092 - 3.70 2 ECs2560 eda -2.65 1
ECs2113 O157 -3.24 1 ECs2574 yebC -2.87 1
ECs2118 ydeV 3.60 2 ECs2575 ntpA -2.15 1
ECs2119 ydeW 2.54 2 ECs2586 argS -2.77 1
ECs2120 - 4.17 2 ECs2609 araF 3.61 2
ECs2126 tam 2.83 2 ECs2613 ftn -3.88 1
ECs2145 ydeI 3.74 2 ECs2614 yecH -2.94 6
ECs2146 ydeJ 2.05 2 ECs2668 yedE -2.15 1
ECs2150 ydfZ -5.10 4 ECs2669 yedF -2.78 1
ECs2281 O157 2.30 2 ECs2670 yedK 2.55 2
ECs2292 - 3.22 2 ECs2693 - 2.62 2
ECs2295 ynfG -2.81 6 ECs2785 erfK 2.37 2
ECs2820 hisG -2.80 1 ECs3458 yfiO -2.61 1
ECs2821 hisD -2.57 1 ECs3465 yfiL 3.81 2
ECs2822 hisC -2.52 1 ECs3469 rplS -4.28 1
ECs2824 hisH -2.22 1 ECs3470 trmD -5.46 1
ECs2837 wbdQ -2.35 1 ECs3472 rpsP -5.57 1
ECs2888 yegP 4.47 2 ECs3520 ygaT 4.88 2
ECs2892 yegS 3.38 2 ECs3522 gabD 2.53 2
ECs2900 fbaB 2.45 2 ECs3523 gabT 3.14 2
ECs2920 metG -2.59 1 ECs3533 ygaM 3.32 2
ECs3022 yohC 6.12 2 ECs3554 alaS -2.20 1
ECs3029 O157 4.04 2 ECs3605 cysN -3.19 1
ECs3030 O157 3.38 2 ECs3617 cysH -2.76 1
ECs3053 yeiJ -2.67 1 ECs3619 cysJ -4.11 1
ECs3055 yeiL 2.38 2 ECs3655 ygdH 2.14 2
ECs3073 yejG 2.91 2 ECs3669 - 2.28 2
ECs3077 rplY -3.64 1 ECs3742 ygeV 3.64 2
ECs3078 yejK -2.55 1 ECs3750 ygfJ 4.14 2
ECs3102 ada 2.24 2 ECs3761 - 2.76 2
ECs3114 gyrA -3.38 1 ECs3762 lysS -2.92 1
ECs3181 pta -3.50 1 ECs3771 - 3.52 2
ECs3224 fadJ 4.26 2 ECs3772 yqfB -2.02 1
ECs3225 fadI 4.50 2 ECs3784 serA -3.66 1
ECs3227 fadL 5.39 2 ECs3810 tktA -4.16 1
ECs3230 yfdC 2.55 2 ECs3815 yqgB -2.40 1
ECs3259 yfdZ 3.57 2 ECs3833 ansB -2.31 4
ECs3271 - 3.06 2 ECs3896 yqhE 2.86 2
ECs3272 nupC -2.08 1 ECs3904 ygiS -2.33 1
ECs3278 gltX -2.47 1 ECs3948 rpsU -3.14 1
ECs3286 cysK -3.68 1 ECs3955 ygjG 5.55 2
ECs3293 cysA -2.71 1 ECs3963 ygjL 4.06 2
ECs3302 yfeX -2.24 1 ECs3979 yqjC 2.12 2
ECs3322 - 2.10 2 ECs3980 yqjD 2.28 2
ECs3323 - 2.15 2 ECs4033 yraR 2.71 2
ECs3338 purC -5.04 1 ECs4034 yhbO 3.67 2
ECs3339 nlpB -2.13 1 ECs4040 yhbV -3.40 1
ECs3369 guaA -2.99 1 ECs4064 rpmA -3.29 1
ECs3397 - 2.55 2 ECs4068 murA -3.01 1
ECs3401 csiE 3.77 2 ECs4069 yrbA -2.73 1
ECs3409 yphA 3.07 2 ECs4091 gltB -3.19 1
ECs3434 lepB -2.08 1 ECs4092 gltD -3.80 1
Table 3: Significant ORFs (p value < 1 × 107) with greater than 4-fold significant changes in expression from late exponential to early 
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ECs3445 yfiD -6.36 6 ECs4104 rplM -4.05 1
ECs4112 yhcO 3.56 2 ECs4404 yhjG 2.50 2
ECs4127 accB -2.57 1 ECs4427 O157 2.20 2
ECs4128 accC -3.51 1 ECs4433 yhjY 3.88 2
ECs4133 fis -3.76 1 ECs4438 yiaE -2.49 1
ECs4159 rplQ -3.99 1 ECs4440 yiaG 2.73 2
ECs4160 rpoA -4.11 1 ECs4449 xylF 2.34 2
ECs4163 rpsM -3.05 1 ECs4463 yiaW 2.75 2
ECs4166 rplO -3.63 1 ECs4464 aldB 3.02 2
ECs4167 rpmD -3.70 1 ECs4473 yibH 3.78 2
ECs4168 rpsE -3.75 1 ECs4475 mtlA 2.84 2
ECs4169 rplR -3.75 1 ECs4511 rpmG -3.21 1
ECs4170 rplF -3.62 1 ECs4514 dfp -2.28 1
ECs4171 rpsH -4.00 1 ECs4554 espB -2.41 1
ECs4172 rpsN -3.13 1 ECs4555 espD -2.60 1
ECs4173 rplE -4.26 1 ECs4611 ilvN 4.84 2
ECs4174 rplX -4.14 1 ECs4612 ilvB 4.41 2
ECs4175 rplN -4.46 1 ECs4633 yidB 3.85 2
ECs4176 rpsQ -4.30 1 ECs4672 glmU -2.20 1
ECs4177 rpmC -4.12 1 ECs4674 atpD -2.97 1
ECs4178 rplP -3.60 1 ECs4675 atpG -3.77 1
ECs4179 rpsC -5.07 1 ECs4676 atpA -4.02 1
ECs4180 rplV -4.74 1 ECs4677 atpH -4.50 1
ECs4181 rpsS -4.14 1 ECs4678 atpF -4.08 1
ECs4182 rplB -4.83 1 ECs4680 atpB -3.27 1
ECs4183 rplW -5.75 1 ECs4684 mioC -2.10 1
ECs4184 rplD -6.50 1 ECs4686 asnA -3.68 1
ECs4185 rplC -4.69 1 ECs4708 ilvC -3.31 1
ECs4186 rpsJ -5.93 1 ECs4757 yigM -2.00 1
ECs4189 - 3.24 2 ECs4758 metR -3.26 1
ECs4191 fusA -3.27 1 ECs4760 - 3.29 3
ECs4210 argD -2.36 1 ECs4774 fadB 6.58 2
ECs4212 fic 4.44 2 ECs4783 dsbA -2.15 1
ECs4213 yhfG 4.13 2 ECs4785 yihG 2.17 2
ECs4232 aroK -3.21 1 ECs4792 glnA -5.34 1
ECs4244 yhgE -3.33 1 ECs4793 yihK -2.43 1
ECs4278 asd -2.55 1 ECs4847 yiiS 2.66 2
ECs4299 ugpB 6.46 2 ECs4869 metL -2.30 1
ECs4348 yhhG -2.67 1 ECs4884 yijP -3.62 1
ECs4398 yhjA -2.20 6 ECs4889 argH -4.04 1
ECs4399 treF 3.03 2 ECs4898 murI -2.51 1
ECs4402 yhjD 2.51 2 ECs4906 rplK -4.80 1
ECs4910 rpoB -2.90 1 ECs5123 groES -3.66 1
ECs4911 rpoC -2.86 1 ECs5130 blc 3.64 2
ECs4914 thiG -2.22 1 ECs5176 rpsF -4.84 1
ECs4915 thiF -2.80 1 ECs5177 priB -5.00 1
ECs4916 thiE -2.34 1 ECs5178 rpsR -4.46 1
ECs4917 thiC -2.35 1 ECs5179 rplI -3.90 1
ECs4928 purD -4.58 1 ECs5185 fklB -2.32 1
ECs4933 aceA 4.98 2 ECs5194 ytfJ 4.59 2
ECs4934 aceK 2.90 2 ECs5205 ytfQ 6.29 2
ECs4990 O157 2.13 2 ECs5206 - 2.57 3
ECs4991 O157 2.12 2 ECs5207 ytfT 3.32 2
ECs5007 lysC -3.43 1 ECs5208 yjfF 2.59 2
ECs5038 pfkA 2.14 2 ECs5211 yjgA 2.20 2
ECs5039 yjbR 2.21 2 ECs5213 cybC 2.20 2
ECs5049 actP 4.17 2 ECs5222 pyrB -2.95 1
ECs5050 yjcH 3.78 2 ECs5253 O157 2.70 2
ECs5089 phnB 4.22 2 ECs5332 yjjG 3.09 2
ECs5109 yjdJ 3.07 2
aGenes with "O157" indicate that these are O157-specific ORFs.
Table 3: Significant ORFs (p value < 1 × 107) with greater than 4-fold significant changes in expression from late exponential to early 
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reported to regulate LEE transcription [48]. The recently
identified chromosomal CcdAB toxin-antitoxin system
[49], encoded by ECs0052 and ECs0053, increased 5.3-
fold from the transition point to early stationary phase
(Table 3, Fig. 3; QTC 2). ECs0415, afuA, encoding a peri-
plasmic ferric iron binding protein, had the greatest
increase in expression of the O157-specific ORFs, with a
37-fold increase during the transition point (Table 3, Fig.
3; QTC 2).
Genes with transient expression at the stationary phase 
transition point
A subset of 120 ORFs were expressed transiently from late
exponential to early stationary phase. These ORFs
changed significantly during the 4.6 to 5 h time interval,
and then again during the 5 to 5.5 h interval, but in the
opposite direction (Fig. 3; QTC 3, 11, and 12). Genes with
this pattern of transcription included many involved in
nutrient scavenging and turnover. Genes encoding both
the anaerobic (glpABC) and aerobic (glpD) sn-glycerol 3
phosphate dehydrogenase increased >4 fold during the
transition into stationary phase, and then decreased sig-
nificantly in early stationary phase (Table 4). This pattern
is consistent with the general model that the glp metabolic
system serves as a salvage pathway for glycerol derived
from degradation of phospholipids and triacylglycerol.
The murPQ operon was expressed transiently, with a 5.3
fold increase followed by a 2 fold decrease in early station-
ary phase. The products of murPQ are involved in pepti-
doglycan turnover [50] suggesting that membrane
components are being recycled and utilized for energy. A
dicarboxylate transporter, dctA, was induced 24-fold upon
entry into stationary phase, then decreased 4-fold in early
stationary phase (Table 4). Genes encoding transport and
binding proteins for carbohydrates, sugar alcohols and
acids were significantly enriched at the stationary phase
transition point compared to mid-exponential phase, also
indicating the release of glucose-dependent catabolite
repression (Additional File 4). Genes encoding salvage
and scavenging pathways are also induced during glucose-
limited growth [51,52] (Additional File 1).
Only 12 O157-specifc ORFs were expressed transiently
upon entry into stationary phase. ECs1772, a putative
intestinal colonization factor, decreased upon entry into
stationary phase, then significantly increased in expres-
sion (>4 fold increase from 5 to 5.5 h) (Table 4).
Genes with a significant change in expression in early 
stationary phase
The interval with the second largest number of signifi-
cantly modulated ORFs was in early stationary phase, dur-
ing the 5 to 5.5 h interval. A number of these ORFs that
had significant increases in expression levels during this
interval are transcriptional regulators, such as the AraC-
like regulators gadW and gadX, involved in regulation of
the glutamate decarboxylase system of acid resistance
(Table 5). Genes encoding DNA binding proteins, such as
hha and cbpA, also increased in transcription in early sta-
tionary phase. Components of the glycerol metabolism
pathway were activated in early stationary phase, includ-
ing ugpC and ugpE, components of the glycerol 3 phos-
phate transporter, and ugpQ, the cytosolic
glycerophosphoryl diester phosphodiesterase (Table 5).
Expression of LEE island genes upon entry to stationary 
phase
Of the 41 LEE island ORFs, 23 had a significant (p  <
0.00001) differences in expression in growth into station-
ary phase under minimal media (Fig. 5). Most of these
ORFs were downregulated in transition to stationary
phase (between 4.6 and 5 h). Three of these ORFs, espB,
espD, and espZ, also had a significant change in expression
in early stationary phase (5 h to 5.5 h). The greatest reduc-
tion in expression was observed in espB and espD, which
both decreased 5.5- fold from late log to early stationary
phase. Expression of espA also decreased > 5- fold over this
interval, but the error variance for the espA probe was large
and thus was not deemed significant. While the overall
trend for the LEE island genes was a decline in expression
during the transition to stationary phase, the exception
was espZ which had a 3.2 fold increase in expression from
late log to early stationary phase, indicating that this ORF
may be activated by stationary phase associated regula-
tors. The LEE ORFs as a group were found to be signifi-
cantly enriched in the 3 h log-phase sample compared to
the 5 h, 5.5 h, and 6 h stationary phase samples (Addi-
tional File 4).
Based on the array data, a significant change in expression
could not be detected for espA or eae as a result of the high
variability in signal for probes targeting those ORFs.
Because  espB, espD and  tir  significantly decreased in
expression, we used Q-PCR to determine if expression lev-
els changed for espA and eae. Q-PCR confirmed the array
data for espB, and detected a 32-fold decrease in espA and
a 16-fold decrease in eae transcript levels from 4.6 to 5.5 h
(Fig. 6A). Overall, the Q-PCR data detected greater
amounts of decrease in espA, espB (22- to 35-fold), tir, and
eae (7- to 16-fold) expression compared to the array data
(3.2-fold decrease for tir and eae, 5- to 7-fold decrease for
espA and espB) for the 4.6 to 5.5 h interval. Transcript lev-
els for espZ were estimated to increase 3.2-fold for the 4.6
to 5.5 h interval from the array data. Q-PCR for espZ found
only a slight change (~1.2-fold) in expression over the
time intervals tested (Fig. 6A). Whereas the Q-PCR meas-
urements did not confirm the increase in expression deter-
mined from the array data for espZ, it is clear that espZ
expression does not follow the same pattern as other
genes on the LEE island.BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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Expression changes of LEE effectors
More than 60 putative effectors that are translocated
through the LEE-encoded TTSS were recently identified
[53] and of these TTSS effectors, 33 were found here to
have significant (p < 0.00001) changes in expression over
time. A total of 7 TTSS effector genes (nleA, nleG, espM1,
espM2, nleG2-2, espZ, and nleG2-3) amplified in expres-
sion between mid- and late- exponential phase (3 h to 4
Table 4: Significant ORFs (p value < 1 × 107) with transient expression at the stationary phase transition point with expression changes 
greater than 4-fold.
Ecs no. gene log2 change in expression 
4.6–5 h
log2 change in expression 
5–5.5 h
QT cluster
ECs0057 pdxA -2.43 0.66 1
ECs0287 O157 -1.09 2.91 2
ECs0358 betB 3.07 -1.25 3
ECs0359 betI 2.99 -1.48 3
ECs0418 O157 2.19 -0.64 3
ECs0486 cyoA 2.77 -1.08 10
ECs0746 sdhC 2.93 -1.74 10
ECs0747 sdhD 2.55 -1.59 10
ECs0748 sdhA 2.76 -1.38 10
ECs0778 nadA -2.57 0.76 1
ECs0946 artI -2.66 0.40 5
ECs0987 focA -3.38 1.11 6
ECs0994 rpsA -3.78 0.66 1
ECs1261 putP 2.80 -0.92 10
ECs1741 adhE -4.01 1.17 6
ECs1744 oppB -2.05 1.36 7
ECs1772 O157 -0.68 2.22 2
ECs2383 pykF -2.42 1.49 un
ECs2387 sufS 0.71 2.17 2
ECs2481 ydjH -2.44 0.84 6
ECs2482 ydjI -2.18 0.81 6
ECs2486 yeaC 3.00 -0.57 2
ECs2487 yeaA 3.08 -0.60 3
ECs3042 mglB 3.96 -1.13 3
ECs3043 galS 2.14 -0.87 3
ECs3117 nrdA 1.83 -3.64 11
ECs3125 glpT 1.65 -2.22 4
ECs3126 glpA 3.61 -2.78 3
ECs3127 glpB 2.59 -2.15 3
ECs3128 glpC 2.92 -2.94 un
ECs3142 yfbF -2.54 1.59 12
ECs3143 yfbG -2.50 1.03 5
ECs3144 yfbH -2.66 0.98 5
ECs3299 yfeU 2.39 -0.89 3
ECs3300 yfeV 2.28 -0.99 3
ECs3305 ypeA 2.05 -0.81 3
ECs3393 hscB -1.37 2.51 7
ECs3748 yqeB 2.23 -0.78 3
ECs4109 mdh 2.05 -1.40 un
ECs4269 glpD 4.17 -1.82 3
ECs4408 dctA 4.59 -1.93 3
ECs4498 rfaF -2.10 0.85 12
ECs4705 ilvD -2.03 1.03 12
ECs4726 yifM 3.51 -3.62 un
ECs4750 yigI 2.77 -1.14 10
ECs4840 fieF 3.76 -3.29 3
ECs4851 glpK 3.54 -3.73 4
ECs4852 glpF 5.22 -4.10 3
ECs4918 yjaE 4.21 -1.58 3
ECs5298 yjiM 0.71 -2.14 8
ECs5313 yjiY 1.38 -3.28 unBMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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h). At the stationary phase transition point, 11 ORFs
increased in expression and 7 ORFs had a significant
reduction in expression (espJ, tccP, tir, espF, espB, espM2,
and nleD). In early stationary phase, eleven ORFs were
upregulated, with the exception of espB  (2.5 fold
decrease). From late exponential to early stationary phase
(4.6 h to 5.5 h), 8 ORFs had an increase in expression > 2-
fold, with espY1 increasing 9 fold. Over this same time
interval, 5 TTSS effector ORFs had a 2-fold or greater
decrease in expression, with espB  decreasing 5.3 fold
(Table 6). Array data for the TTSS effectors espY1  and
espM1 indicated an increase in expression from exponen-
tial to stationary phase, which was reflected in the Q-PCR
data for these ORFs (Fig. 6B). Expression of the TTSS espJ
decreased in stationary phase and a 21 -fold decrease in
expression during the transition from log to stationary
phase (4.6 to 5 h) was determined by Q-PCR (Fig. 6B).
Significant increase of genes from the acid fitness region in 
stationary phase
A cluster of 12 genes located in the E. coli K-12 genome at
position 3652706 to 3665603 bp has recently been
termed the acid fitness island (AFI) [54]. In E. coli
O157:H7 Sakai genome, the homologous region contains
a 9 kb insertion between yhiF  (ECs4378) and yhiD
(ECs4388). This AFI genomic region contains multiple
transcriptional regulators that control expression of the
glutamate dependent acid resistance (GDAR) system,
such as GadE, GadX, and GadW, that are also known to
influence LEE expression [55,56]. The microarray compar-
isons demonstrate that the expression of the AFI genes
increased significantly from exponential to stationary
phase, and included some of the greatest increases in tran-
script level among the whole genome (Fig. 7). Transcript
levels of gadA  increased 111 fold and levels of gadE
increased 85 fold from mid-exponential (3 h) to station-
ary phase (6 h). Over half of the AFI genes (7/12) had a
significant increase in expression from mid- to late- expo-
nential phase (Fig. 7). Transcript levels of gadA, gadE, and
slp also increased significantly from 4.3 to 4.6 h, which is
different from the expression profiles of the other known
stationary phase activated genes that increase from 4.6–5
h. GSEA found the AFI ORFs as a group to be significantly
Table 5: Significant ORFs (p value < 1 × 107) with greater than 4-fold expression changes in early stationary phase.
Ecs no. gene log2 change in 
expression 
5-5.5 h
QT cluster Ecs no. gene log2 change in 
expression
5–6 h
QT cluster
ECs0342 ykgC 2.30 2 ECs0568 gcl 4.04 2
ECs0513 hha 2.55 2 ECs0569 gip 3.56 2
ECs0514 ybaJ 2.16 2 ECs0570 ybbQ 4.89 2
ECs0732 ybgA 2.27 2 ECs0571 ybbV 3.27 2
ECs0733 phrB 2.15 2 ECs2095 yddV 4.27 2
ECs0769 cydB -2.03 4 ECs2122 ydeZ 4.88 2
ECs0957 poxB 2.47 2 ECs2123 yneA 5.14 2
ECs0973 trxB -2.25 1 ECs2124 yneB 4.46 2
ECs1155 cbpA 2.26 2 ECs2705 yedU 4.54 2
ECs1236 lomW 2.21 2
ECs1756 yciD -3.21 4
ECs2047 ydcV 3.59 2
ECs2048 ydcW 2.35 2
ECs2386 ynhA 2.75 2
ECs2388 ynhC 2.89 2
ECs2493 yeaH 4.26 2
ECs2529 manZ -2.65 1
ECs3395 iscU 2.61 2
ECs3396 yfhO 2.04 2
ECs4046 rpsO -2.20 1
ECs4295 ugpQ 2.20 2
ECs4296 ugpC 2.60 2
ECs4297 ugpE 2.12 2
ECs4305 livK -2.23 1
ECs4395 gadW 2.10 2
ECs4396 gadX 2.76 2
ECs4534 intL 2.50 2
ECs4673 atpC -2.24 1
ECs5108 yjdI 2.20 2
ECs5269 yjhT 3.09 2BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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Heatmap of gene expression over time for the ORFs of the LEE Pathogenecity Island Figure 5
Heatmap of gene expression over time for the ORFs of the LEE Pathogenecity Island. Expression values deter-
mined from the ANOVA analysis are represented colorimetrically, with dark red representing expression = 1.8 and dark green 
representing expression = -1.8 on a log2 scale. ORFs marked with an asterisk denotes that a statistically significant change in 
expression levels of that ORF was detected for at least one time point.
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enriched in all of the time points subsequent to the mid-
exponential phase sample (Additional File 4).
Increased expression of Shiga toxin genes upon entry into 
stationary phase
More than 50% of Sp 15 ORFs and 60% of Sp 5 ORFs had
significant (p < 0.00001) changes in expression over time
into stationary growth phase. The genes encoding Shiga
toxin 1, stx1A and stx1B, as well as those encoding Shiga
toxin 2, stx2A and stx2B, had a significant difference in
expression between mid- and late- log phase (3 to 4 h).
Stx1 genes decreased ~1.8 fold over this interval, while
Stx2 genes increased ~1.7 fold. Stx1 genes increased signif-
icantly in early stationary phase, with a ~4- fold increase
from 5 to 6 h. A significant 2.5- fold increase for stx2B
occurred at the transition point into stationary phase, but
a concomitant increase was not observed for the stx2A
ORF on the microarray. Q-PCR was used to monitor
expression of stx1A, stx2A, and stx2B over time (Fig. 8).
Expression of stx1A decreased 4-fold from mid-exponen-
tial phase to the stationary phase transition point, and
then increased 2-fold during early stationary phase (5 to 6
h interval), which is similar to the array data. A 2-fold
increase in expression from mid- to late- log phase was
observed for stx2B using Q-PCR. While stx2B transcript
levels remained higher in stationary phase compared to
exponential phase, a subsequent increase during the sta-
tionary phase transition was not observed. Transcript lev-
els of stx2A  increased 1.5-fold from mid- to late-
exponential phase, and decreased 1.5-fold from late expo-
nential to stationary phase (Fig. 8). The ORFs encoding
the phage replication factors O and P, as well as the CII
regulatory protein and the Q antiterminator protein,
increased in expression upon entry into stationary phase,
but it is difficult to attribute these ORFs to a specific
phage, as there are multiple copies of these ORFs through-
out the genome.
Expression changes in tellurite resistance genes and urease 
genes
Proteins involved in tellurite resistance are encoded on a
pathogenicity island (TAI) along with genes encoding ure-
ase and are present in a single copy in E. coli O157:H7
Sakai [16]. Significant changes in expression over time
were detected only for terZ, terD, and terE  (Fig. 9A).
Probes targeting terB and terC are not present on the array.
Expression of these three genes increased significantly
between mid- and late- exponential phase (~1.5 fold) and
then decreased 5.9- to 7.4- fold during the transition into
stationary phase and in early stationary phase (4.6 h to 5.5
h interval). These three ORFs were grouped into QT clus-
ter 1. The ureD, ureA, ureC, ureE, and ureG ORFs had a sig-
nificant reduction in expression from late exponential to
early stationary phase (1.5 to 3 fold) and were grouped
into QT cluster 1 (Fig. 9B). Also located on this genomic
Relative changes in expression for virulence-associated genes  from the LEE Pathogenecity Island Figure 6
Relative changes in expression for virulence-associ-
ated genes from the LEE Pathogenecity Island. A. 
Expression differences of 5 genes transported through or 
adherence components of the LEE island as determined by 
Q-PCR. B. Expression differences of 3 genes encoding effec-
tors (Esp) molecules transported through the LEE Type III 
Secretion System (TTSS) as determined by Q-PCR results. 
Average changes in expression for 2 independent replicate 
cultures were determined relative to the transcript level of 
each ORF at the 3 h mid-exponential phase time point.
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island is the adherence factor iha [57], but there is no sig-
nificant change in iha mRNA over time. Quantitative real-
time PCR targeting terZ and ureD confirmed the reduced
expression of these ORFs from exponential to stationary
phase, detecting an 8-fold decrease for terZ and ureD (Fig.
9C).
Discussion
By monitoring global transcript levels over time, we have
measured the numerous alterations in gene expression
patterns of E. coli O157:H7 when growing exponentially
and then entering stationary phase in minimal medium.
E. coli O157:H7 responded to low O2 by increasing expres-
sion of genes encoding anaerobic electron acceptors and
decreasing expression of genes encoding the TCA cycle.
O157-specific ORFs, including nleA  and  nleG, which
encode TTS effectors, were upregulated during this inter-
val. As cells entered stationary phase, ~50% of the ORFs in
the genome responded with significant changes in tran-
Relative changes in expression of Shiga toxin genes Figure 8
Relative changes in expression of Shiga toxin genes. 
Changes in expression of the phage-encoded toxin genes 
stx1A, stx2A, and stx2B as determined by Q-PCR. Average 
changes in expression for 2 independent replicate cultures 
were determined relative to the transcript level of each ORF 
at the 3 h mid-exponential phase time point.
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Table 6: Significant changes in transcript levels of Type III secretion system (TTSS) effectors.
ECs number Gene name Log2 change in expression from 4.6 h to 5.5 h
ECs0061 espY1 3.03
ECs0073 espY2 1.24
ECs1825 espM1 1.47
ECs1994 nleG2-2 1.41
ECs2156 nleG2-3 1.63
ECs2229 nleG2-4 -1.15
ECs2714 espJ -2.18
ECs2715 tccP -1.39
ECs3488 nleG6-3 1.11
ECSs4554 espB -2.41
ECs4561 tir -1.72
ECs4571 espZ 1.69
ECs4643 espL3 1.77
Expression heat map of 12 genes from the acid fitness region  (AFI) Figure 7
Expression heat map of 12 genes from the acid fit-
ness region (AFI). Expression values determined from the 
ANOVA analysis are represented colorimetrically, with dark 
red representing expression = 3 and dark green representing 
expression = -4 on a log2 scale. Over half of the AFI genes 
(7/12) had a significant increase in expression from mid- to 
late- exponential phase
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script level. The global trends include down regulation of
some of virulence factors, such as the components of the
TTSS and some of the TTSS effectors, in stationary phase.
Other TTSS effectors and the genes encoding Shiga toxin
increased in transcript level upon entry to stationary
phase. Entry into stationary phase was characterized by
the increase in expression of known stress and survival
related genes, such as the osmotic stress proteins encoded
by  osmB  and osmC, and the glutamate dependent acid
resistance system encoded by gadA and gadBC.
As E. coli O157:H7 cells grew in the minimal medium, O2
levels in the medium decreased and were not replenished
from the atmosphere (Fig. 4). The decrease in available
oxygen was reflected in the transcriptome, with significant
increases in genes encoding anaerobic electron acceptors,
decrease in transcript levels of TCA cycle genes, and
increase in expression of pyruvate formate lyase and con-
comitant decrease in expression of the pyruvate dehydro-
genase complex. Decreased expression of cyo  and  sdh
operons, with concurrent increased expression of the cyd
operon was also observed during anaerobic growth of E.
coli K-12 at pH 4.7 compared to aerobic growth at acidic
pH [28] (Additional File 1). 5% (73/1239) of O157-spe-
cific ORFs also had significant changes in expression over
the same time interval, which leads one to speculate that
these O157-specific ORFs may be regulated by transcrip-
tion factors that influence expression of respiratory genes,
such as FNR and ArcA. Virulence factor expression in
enteric pathogens, such as Salmonella enterica serovar
Typhimurium and Vibrio cholerae, can be controlled by the
redox state regulators FNR and ArcA [58-60]. A search for
the FNR and ArcA binding sequences 500 bp upstream of
all ORFs in the Sakai genome (using Pattern Search on
coliBASE [61]) did not identify any of the ORFs that were
significantly expressed or repressed in exponential phase.
It may be that these O157-specific ORFs are regulated
indirectly through FNR or ArcA, or are modulated in a
completely different manner. Recently Ando et al. [62]
demonstrated that anaerobic growth in the presence of
the electron acceptors nitrate or TMAO accelerates matu-
ration of the TTSS, independently of new protein synthe-
sis. They found that the narGHIJ operon must be present
for the maturation of the TTSS. Our findings indicate that
the expression of this operon increases significantly in late
exponential phase, which is consistent with the narGHIJ
operon contribution to the maturation of the TTSS in this
environment.
Much is known about regulation of LEE expression; mul-
tiple circuits of activation and repression have been iden-
tified. LEE expression can be induced in response to a
number of environmental stimuli, and while common
transcriptional regulators and signaling systems can acti-
vate LEE expression, they all typically act on Ler or the
Expression profiles of 12 ORFs encoded on the tellurite  resistance island (TAI) Figure 9
Expression profiles of 12 ORFs encoded on the tellur-
ite resistance island (TAI). Expression values determined 
from the ANOVA analysis are plotted over time for the A. 
tellurite resistance and B. the urease-encoding ORFs. C. 
Average relative expression of terZ and ureD was determined 
by Q-PCR of two independent replicate cultures.
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recently described GrlA and GrlR regulators located on the
LEE island [63], which then alter expression of other LEE
genes. As LEE expression is thought to be maximal under
conditions similar to the intestinal environment [11], we
would expect to see increased expression of LEE under
these conditions compared to the minimal medium used
here. We did observe similar growth-phase dependent
changes in expression in the LEE genes that has also been
observed for O157:H7 grown in rich medium. LEE expres-
sion is known to be maximal in late exponential phase
[12,64]. Nakanishi et al. determined that LEE can be stim-
ulated during nutrient downshifts through activation of
ppGpp and DksA [10]. The pattern of espB  expression
observed during induction of LEE with ppGpp is similar
to our observation, in that espB  and  espA  expression
increases from mid- to late-exponential phase, and then
decreases in stationary phase (Fig. 5 and Fig. 6A). LEE
transcription can also be stimulated by quorum sensing,
via the auto-inducer 3 signaling system that activates ler
[12]. The quorum sensing activated regulator QseA which
activates LEE transcription [65] had a decrease in tran-
script levels from exponential to stationary phase (Fig. 3;
QTC 1). Many of the common E. coli regulators that have
been shown to repress LEE expression, such as Hha [66],
SdiA [67], GadE [56], YhiF [56], and IHF [68,69], all
increased in mRNA levels from exponential to stationary
phase (Table 2, Fig. 3; QTC 2). Other LEE activators, such
as PchC [48], had a significant increase in mRNA in sta-
tionary phase.
The decrease in expression of LEE genes from exponential
to stationary phase that we observed is similar to the
expression changes of LEE genes when O157:H7 is
attached to red blood cells [34]. In comparing our dataset
to the genes that were found to be significantly up- or
down-regulated in O157:H7 attached to red blood cells,
we found that of the 299 ORFs reported to be down regu-
lated in attached cells, 185 had significant changes in
expression over time, and 73% of these ORFs were classi-
fied in QT cluster 1 (Fig. 3), which includes the LEE genes.
Of the 105 ORFs reported to be upregulated in attached
cells, 89 had significant changes in expression over time,
and 56% of these significant ORFs were placed in QT clus-
ter 2 (Fig. 3), suggesting that many of the ORFs expressed
or repressed during attachment to plasma membranes are
also regulated by growth phase.
Not as much known about regulation of non-LEE
encoded TTSS effector genes. The presence of some of the
TTSS effectors in the genome is variable among O157
strains [70]. The TTSS effectors tccP and espJ are located on
Sakai phage 14 (EDL-933 OI#79); tccP (espFu) is necessary
for actin recruitment and A/E lesion formation in E. coli
O157:H7, while espJ  influences colonization dynamics
[71-73]. Reading and colleagues recently determined that
the AI-3, epinephrine, and norepinephrine response regu-
lator QseF (yfhA) is an indirect transcriptional activator of
tccP [74]. Our data indicate that as Sakai O157:H7 entered
stationary phase, qseF mRNA levels decrease significantly
(2 fold) (QTC 1) and tccP-espJ levels decreased signifi-
cantly as well. This decrease in tccP and espJ transcript lev-
els in stationary phase is in contrast to a previous study,
where the activity of the tccP-espJ promoter was found to
be the same in exponential vs. stationary phase cultures of
EDL-933 in Dulbecco's Modified Eagle Medium as moni-
tored by a gfp  fusion [75]. Some of the TTSS effectors
appear to respond to low O2 conditions, as 7 effectors
increased significantly from mid- to late-exponential
phase when oxygen levels decreased. Of the TTSS effectors
with significant changes in expression over time, ~50%
have decreased expression from exponential to stationary
phase, while the other half have increased expression in
stationary phase. Several of these TTSS effectors are pre-
dicted to be pseudogenes; one example is espL3, an ORF
that was found to have a significant increase in expression
at the stationary phase transition point. Many of the TTSS
effectors with increased expression levels in stationary
phase are members of the NleG family (Table 6), one of
the largest families of TTS effectors that contain many
duplications [53]. The utility of the increased expression
of some of the TTS effectors in stationary phase is unclear
and warrants further investigation.
The ability to resist low pH is a crucial adaptation and crit-
ical component of the low infectious dose of E. coli
O157:H7. The GDAR system provides the greatest protec-
tion against low pH, allowing survival at levels of gastric
acidify (e.g. pH 2.0) as long as glutamate is present in the
environment [76]. Genes encoding the glutamate decar-
boxylase isozymes and the glutamate-gamma-aminobu-
tyric acid antiporter are under tight control and can be
activated via a number of environmental cues and tran-
scriptional regulators [77], and many components of the
system are located in the AFI region [54]. Also located on
the AFI are hdeA, slp, and yhiF, which encode proteins
involved in protecting cells from their metabolic by-prod-
ucts when the medium is acidified, and yhiD and hdeD,
which are required for density-dependent acid resistance
[78]. ORFs of the AFI are induced by a variety of stressful
environments, including growth in the presence of acetate
[79], anaerobic, low pH growth [28], during attachment
to red blood cells [34], and in stationary phase [23].
Induction of the AFI ORFs as a response to multiple types
of stresses highlights the importance of acid stress survival
to the route of transmission for E. coli. Transcription fac-
tors located on the AFI, such as GadE and GadX, regulate
a large number (>40) of ORFs outside of the GAD system
in E. coli K-12 [54,80], and it is known that these factors
serve as repressors of LEE transcription [55,56], but it isBMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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unknown what the effect of these regulators are on a
genome-wide scale in E. coli O157:H7.
Chromosomal Toxin-antitoxin (TA) loci encode TA sys-
tems which are thought to induce reversible stasis, allow-
ing survival during episodes of extreme nutritional stress
[81,82]. Increased expression of TA loci in E. coli K-12 dur-
ing growth transitions led to the development of a model
integrating inhibition of all macromolecular synthesis
within the stringent response model [23], while recent
findings suggest that the chromosomal TA systems do not
significantly influence bacterial fitness during nutrient
limitation [83]. E. coli O157:H7 has some of the same TA
loci as E. coli K-12; dinJ-yafQ [84], chpAR, chpBS [85], as
well as the recently described chromosomal ccdAB system
that is present in E. coli O157:H7 and not in E. coli K-12
[49]. CcdB encodes a DNA gyrase toxin [49], chpB encodes
a translation inhibitor [86], and yafQ encodes an mRNA
endoribonuclease [84]. Here we observed increased
expression of the dinJ-yafQ, chpBS, and ccdAB TA loci upon
entry to stationary phase, indicating that these systems are
actively transcribed in stationary phase, but their utility
remains to be elucidated.
Important questions remain about the factors regulating
the Shiga toxins which are encoded by lambda-like bacte-
riophages [7]. These phages can be transferred between
many E. coli strains in nature and were the principal viru-
lence factors acquired as a key step in the evolution of E.
coli  O157:H7 [87]. How they become influenced in
expression and regulated when acquired into a new
genome is not fully understood. Early work described two
types of Shiga toxin [88] encoded by Stx1 and Stx2, both
located within the late operons of the Stx-encoding
phages [89,90]. Stx1 expression is regulated in part by the
iron-dependent transcriptional repressor, Fur [15]. Expo-
sure of E. coli O157:H7 to low iron conditions result in an
increase of stx1  transcription [14]. Our growth experi-
ments indicate that the stx1 genes decrease in expression
from mid- to late-exponential phase, at the same interval
when O2 levels decrease (Fig. 8). Iron becomes more sol-
uble as O2 concentration decreases, which could lead to
the decreased stx1  expression. Stx1 expression can be
induced at 2 other promoters in addition to the Fur bind-
ing site, those that require the phage anti-terminator Q
[91] and the phage anti-terminator N [14]. Stx2 transcrip-
tion is initiated at the late phage promoter and is depend-
ent on the anti-repressor Q protein [13]. The production
of Stx2 is part of the lytic cycle of the bacteriophage, and
can be induced by antimicrobials [92,93]. Herold et al.
found that phage genes were induced upon exposure of E.
coli O157:H7 EDL-933 to norfloxacin; phage late genes
and stx2 were induced 150-fold [35]. Levels of stx2 mRNA
are higher in starved O157:H7 compared to exponentially
growing cells [94], indicating an overall trend of stx2
expression induction by stress. Here we observed that stx1
expression increased in stationary phase and stx2 expres-
sion was higher in stationary phase compared to exponen-
tial phase (Fig. 8). Herold et al. also reported that stx2A is
transcribed more efficiently than stx2B in O157:H7 EDL-
933, and may be regulated at the posttranscriptional level
[35]. This difference in transcription efficiency between
stx2A and stx2B was not reflected in our data, as stx2A lev-
els did not appear to increase as the stx2B levels did in sta-
tionary phase.
The genomic island termed the Tellurite and Adherence
Island (TAI) contains genes encoding tellurite resistance,
urease, and an adherence factor, iha  [57]. The urease
operon and the tellurite genes are thought to be ubiqui-
tously distributed in EHEC strains [95,96] but is not
present in O157:NM or O55:H7 strains [97]. Urease activ-
ity has been detected in relatively few EHEC strains. In
O157:H7 Sakai, the urease genes have been detected at the
transcript level, but a functional protein is not produced
due to a stop codon present in ureD [98]. Saridakis et al.
surveyed 25 O157:H7 strains that were isolated from
humans, cattle, and pigs for ureC and the ability to resist
low pH using the urease enzyme. UreC was detected in all
of the isolates but there was no evidence for urease-medi-
ated acid resistance [99]. Here we see that the genes
encoding urease are expressed during exponential growth
and transcript levels decrease significantly as cells enter
stationary phase. The genes encoding tellurite resistance
are functional in EHEC, and can be separated into two
classes – those that are expressed constitutively during
growth (terDEZ) and those that are expressed only during
growth in the presence of tellurite (terBCF) [96]. Our data
show this as well, with terD, E, and Z all expressed during
exponential growth, with a significant decrease in tran-
script levels upon entry to stationary phase, and no signif-
icant changes in transcript levels for terA and F.
As E. coli O157:H7 cells transitioned to stationary phase,
we observed a transient increase in expression of ORFs
encoding proteins involved in acquisition and utilization
of alternative carbon sources. ORFs involved in acetate
uptake and utilization increased in expression, and some
of these genes, such as acs, are known to be controlled, in
part, by RpoS [46]. RpoS is activated during slow growth
on glucose [52], and growth on less desirable carbon
sources [100]. RpoS is also activated during the switch
from one carbon source to another, as observed in E. coli
K-12 growing in a rich medium [33] and in minimal
medium [23]. The glyoxalate shunt is thought to play an
important role under glucose-limited conditions, where
the absence of catabolite repression is an important factor
for activity of the cycle [101]; here we observed that ORFs
encoding glyoxalate shunt enzymes increased in expres-
sion as E. coli O157:H7 entered stationary phase (Tables 3BMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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and 4). Over expression of high affinity sugar transporters
occurs during the short-term adaptation of E. coli K-12 to
carbon-limited growth [52,102]. Sugar transporters and
carbon uptake systems are also activated in E. coli K-12
during growth on less desirable carbon sources [100]. In
E. coli O157:H7, we observed increased expression of
ORFs encoding transport systems for carbohydrates, sugar
alcohols and acids during the transition to stationary
phase. These data suggest that as glucose was depleted,
other carbon sources were sought, but were not available
in the minimal medium. In a rich medium, we would
expect cells to resume growth, albeit at a lower rate, once
glucose was consumed.
Transition to stationary phase is characterized by complex
physiological changes to the bacterial cell. Many of the
changes in expression patterns observed for O157:H7 in
this study have also been observed for E. coli K-12 entering
stationary phase [23]. Growth under stressful conditions,
such as in the presence of acetate [79] or at low pH under
anaerobic conditions [28], also induce expression of sta-
tionary phase associated genes. The sigma factor RpoS
plays a critical role in transcribing genes associated with
stationary phase and stress response [24-26], many of
these genes, such as bolA, dksA, osmC, and osmB, have been
identified in this study as well. We still do not know about
most of the O157-specific ORFs, and what regulators con-
trol their expression. Here we have classified some of the
well-known O157 genes, as well as O157 genes of
unknown function, as being modulated during growth
transitions. Global transcriptional profiling of isogenic
mutants for a specific regulator have been conducted for a
number of regulators in E. coli K-12. As we know more
about the regulation of virulence loci, such as the LEE, by
global regulators, it would be very useful to perform these
profiling experiments in E. coli O157:H7 and other path-
ogenic E. coli.
Conclusion
The principal contribution of this study is the first com-
plete description of global transcriptome profiling of the
human pathogenic strain, E. coli O157:H7, during growth
transitions. Many O157-specific ORFs responded to the
growth transition with significant changes in gene expres-
sion including multiple genes that are encoded on patho-
genicity islands or toxin-converting bacteriophages.
Because a majority of the O157-specific ORFs have
unknown functions, these findings will have practical use
for comparing transcriptional responses to a variety of
growth conditions and elucidating the function and fac-
tors regulating these unknown ORFs, some of which may
contribute to disease processes. These results also generate
new hypotheses and provide opportunities to identify
ORFs of interest, based on expression profiles, and com-
pare expression within E. coli O157:H7 populations or
with other EHEC populations. It is useful to understand
what transcriptional changes occur from exponential to
stationary phase, as these transitions are important adap-
tations to the growth and survival of E. coli O157:H7 in
natural conditions.
Methods
Growth conditions
E. coli O157:H7 RIMD0509952 (Sakai) involved in a rad-
ish sprout outbreak [103] was stored at -70°C in LB broth
and 10% glycerol. The Sakai strain was inoculated into 10
mL of LB broth from freezer stocks and grown to OD600 =
0.1. This ~4 h period of growth in LB allowed cells to
recover before transfer to MOPS minimal media. MOPS
minimal media (10×) was prepared as described in Nei-
dhardt et al. [104] with the addition of 20 mL of micronu-
trient solution instead of 10 mL. MOPS minimal media
contained 100 mL of 10× MOPS minimal media, 10 mL
of 0.132 M K2HPO4, and 5 mL of 20% D-glucose per liter.
Cultures were inoculated into 50 mL of MOPS minimal
media with 0.1% glucose at a ratio of 1:200 and grown to
stationary phase at 37°C with shaking. Cultures in MOPS
were transferred to 100 mL MOPS in 250 mL plastic cul-
ture flasks (Nalgene, Rochester, N.Y.) at a ratio of 1:75 and
grown for 9 h before transfer again to 100 mL MOPS in
250 mL plastic culture flasks at a ratio of 1:30 and this cul-
ture was used to sample RNA during growth (Fig. 1). Four
independent cultures were sampled at 3 h (OD600 ≈ 0.22),
4 h (OD600 ≈ 0.45), 4.33 h (OD600 ≈ 0.73), 4.66 h (OD600
≈ 0.93), 5 h (OD600 ≈ 1), 5.5 h, 6 h, 7 h, 7.5 h, and 8 h.
After 5 h, the culture density remained at OD600 ≈ 1. Resid-
ual dissolved oxygen tension was monitored using a dO2
probe and Consort C535 multimeter (Topac Instrumenta-
tion, Hingham, Mass.) for three independent cultures in
MOPS minimal medium.
RNA isolation
At each time point, 4 mL of culture was mixed with 8 mL
of RNAProtect (Qiagen, Valencia, Calif.), vortexed, and
centrifuged at 4°C, 7500 rpm for 10 min to pellet cells.
The supernatant was removed and cell pellets stored at -
70°C for 1 week or less before RNA extraction. Cell pellets
were suspended in 700 uL of 95C lysis buffer (20 mM
sodium acetate pH 5.2, 2 mM EDTA pH 8.0, and 0.5%
SDS), held at 95°C for 30s then mixed with 700 uL of
65°C Acid-Phenol: Chloroform, pH 4.5 (with IAA,
125:25:1) (Ambion, Austin, Tex.). Samples were held at
65°C with periodic shaking for at least 6 minutes before
centrifuging at 12000 rpm for 10 min. Supernatant was
extracted again with acid-phenol:chloroform and then
with chloroform:isoamyl alcohol (24.1). RNA was precip-
itated for at least 1 hour at -20°C in 2.5 V 100% ethanol
and 1/10 V 3 M sodium acetate pH 5.2. RNA was sus-
pended in 1 mM sodium citrate pH 6.5 and stored at -
70°C. RNA samples were purified and treated with DnaseBMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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using the Rneasy kit (Qiagen). RNA quality was assessed
by electrophoresis on formaldehyde-agarose gel. RNA was
checked for complete DNA digestion by PCR.
cDNA synthesis and hybridizations
Reverse transcription reactions contained 6 ug RNA, 2 ug
random primers (Invitrogen, Carlsbad, Calif.), 1× first
strand buffer (Invitrogen), 10 mM DTT, 400 U Superscript
II (Invitrogen), 0.5 mM each dATP, dCTP, and dGTP, 0.3
mM dTTP, and 0.2 mM amino-allyl dUTP. 30 uL reactions
were incubated overnight at 42°C. cDNA was purified
using PCR cleanup columns (Qiagen) with Phosphate
wash buffer (5 mM K2HPO4, pH 8.0, 80%EtOH) and
phosphate elution buffer (4 mM K2HPO4, pH 8.5).
Amino-allyl labeled cDNA was dried and suspended in
0.1 M sodium carbonate pH 9.3 and coupled with either
Cy3 or Cy5 (Amersham Biosciences, Piscataway, N.J.).
Uncoupled dye was removed by another purfication using
the PCR cleanup kit. Concentration of cDNA and amount
of incoporated dye was measured for each sample using a
Nanodrop spectrophotometer (Ambion).
Oligo microarray
The E. coli oligo set version 1.0.1 (Operon) was printed
onto Corning UltraGaps (Corning Incorporated, Acton,
Mass.) coated slides at the Research Technology Support
Facility at Michigan State University. The Qiagen oligo set
contained 5,978 probes specific for three E. coli strains, K-
12 (MG1655) [105], O157:H7 Sakai [16], and O157:H7
EDL-933 [17], in which 5,943 probes were 70-mer oligo-
nucleotides, and 35 probes had lengths that ranged from
41–69 bp. All of these probes are spotted in duplicate on
each array. The oligo set also contained 12 randomized
negative control 70-mer oligonucleotides. There are a
common set of 3807 probes that target 3807 ORFs present
based on the genome sequences of E. coli K-12 MG1655,
E. coli O157:H7 EDL-933, and O157:H7 Sakai, which we
refer to as the backbone ORFs. There are also 1741 probes
targeting ORFs that are specific to one or two of the
genomes, typically to O157:H7 EDL-933 and Sakai. These
probes are referred to as the O157-specific ORFs. Probes
designed to target K-12-specific or EDL-933 specific ORFs
were not considered after the data analysis stage because
these genes are not present in the Sakai genome. We used
the Qiagen annotation for the probe set, and analyzed
only the 4886 probes that were assigned a ECs number.
Hybridization conditions
Arrays were cross-linked by exposure to 600 mJ UV before
blocking in 1% SDS, 5× SSC, and 1 mg/mL BSA at 42°C
for 1 hour. After blocking, arrays were washed 2× 5 min in
0.1× SSC and 2× 30 s in H2O. Dried arrays were placed
into hybridization cassettes (TeleChem International,
Sunnyvale, Calif.) and the cDNA samples were suspended
in 10 mM EDTA, denatured at 95°C for 5 min and then
mixed with 40 uL of SlideHyb buffer 1 (Ambion) and
loaded under a coverslip onto the array. Hybridizations
were carried out at 47°C for 16–18 h. After hybridization,
arrays were washed in 2× SSC, 0.5% SDS 37C for 5 min,
followed by 2× 5 min in 0.1× SSC, 0.1% SDS 37°C, and
then 2 × 2.5 min in room temperature 0.1× SSC. Arrays
were scanned using an Axon 4000b scanner (Molecular
Devices, Sunnyvale, Calif) and images were analyzed
using GenePix 6.0 (Molecular Devices). The 3 h sample
served as a common reference and was hybridized with all
subsequent samples. Array data have been deposited at
the NCBI Gene Expression Omnibus (Accession
GSE7477).
Quantitative real-time PCR
Expression levels of 14 ORFs determined to be differen-
tially expressed (p < 0.00001) were verified by quantita-
tive real-time PCR (Q-PCR). Primer pairs were designed
based on the published reference genome sequence of E.
coli O157:H7 strain Sakai using the Primer3 server, and
secondary structure scrutinized using the Mfold algorithm
[106,107] (Additional File 4). cDNA was synthesized
from 1 ug of total RNA using the iScript Select cDNA syn-
thesis kit (BioRad, Hercules, Calif.) and random hexamers
supplied with the kit. Template cDNA was diluted to 10-1
to 10-3 for use in Q-PCR. Q-PCR reactions contained 12.5
uL 2× iQ SYBR green supermix (BioRad), 0.63 uL of each
primer (10 uM stock), 9.24 uL H2O, and 2 uL cDNA and
were conducted under the following conditions: 2 min at
95C, followed by 40 cycles of 10 sec at 95C then 20 sec at
the specific annealing temperature. Q-PCR reactions were
performed in triplicate for each cDNA sample tested. Rel-
ative expression was determined using the method
described by Pfaffl et al. [108] and the fluorescence data
from the 16S rRNA target were used for normalization
within samples. All samples were then compared to the
expression levels of the mid-exponential (3 hour) sam-
ples. The average log2 expression and standard deviation
from two independent RNA samples are reported for each
time point tested.
Data analysis
Raw intensity values for all probes on each array were nor-
malized using pin-tip LOWESS [109] in R v.2.2.1 [110]
with the MAANOVA (v. 0.98–8) package [111]. Signals
from two replicate probes on each array were averaged
and log2 transformation applied. Differences in transcrip-
tion levels over time were determined using a mixed
model ANOVA in R/MAANOVA, where the log trans-
formed intensity data, Y = A (array) + D (dye) + T (time)
+ S (sample = biological replicate) + E (error). The
ANOVA modeling allows for consideration of appropriate
error structures for experiments with multiple sources of
variation in microarray measurements [112]. The random
effects of the model were biological replicate and arrayBMC Microbiology 2007, 7:97 http://www.biomedcentral.com/1471-2180/7/97
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effects, whereas the fixed effects were time point and dye
effects [113]. The Fs statistic, a shrinkage estimator for
gene-specific variance components that makes no
assumptions about the distribution of variances across
genes, was estimated [40]. Significant changes in expres-
sion over time were determined by calculating the p val-
ues for the Fs statistic for each gene using 1000 random
permutations. The p-values were adjusted to correct for
type I error with the Benjamini-Hochberg (B-H) linear
step-up correction implemented in R/MAANOVA and a
cutoff adjusted p-value of 0.0000001. Pair wise contrasts
of time points were estimated by the t-test in R/
MAANOVA. Contrast p-values were corrected for multiple
testing by using the B-H step-up correction. Probes with
significant changes in expression over time were grouped
by the time points at which the significant change
occurred, as determined by the contrast analysis (adjusted
p value < 0.05). QT clustering of significant ORFs was con-
ducted in MeV v. 3.1 [116] with a diameter of 0.4 and a
minimum cluster size of 15.
Gene Set Enrichment Analysis (GSEA) [114] was con-
ducted using GSEA v. 2.0 [115] on a ranked list of log2
expression ratios (determined from the ANOVA esti-
mates) for 5 of the time points relative to the mid-expo-
nential time point. The following parameters were used
for the analysis: 1000 permutations and exclusion of gene
sets with less than 5 members and greater than 700 mem-
bers. Gene sets were defined based on the E. coli O157:H7
Sakai role categories obtained from the Comprehensive
Microbial Resource at The Institute for Genomic Research
[116]. The GSEA results are summarized in Additional File
4. All gene sets determined to be enriched with a FDR (q-
value) less than 0.25 are reported.
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